These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 26902485
1. Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers. Rai M, Ahlberg AW, Marwell J, Chaudhary W, Savino JA, Alter EL, Henzlova MJ, Duvall WL. J Nucl Cardiol; 2017 Apr; 24(2):724-734. PubMed ID: 26902485 [Abstract] [Full Text] [Related]
2. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers. Gowdar S, Ahlberg AW, Rai M, Perucki WH, Felpel KD, Savino JA, Alter EL, Henzlova MJ, Duvall WL. J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834 [Abstract] [Full Text] [Related]
3. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A. J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040 [Abstract] [Full Text] [Related]
4. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. El-Hajj S, AlJaroudi WA, Farag A, Bleich S, Manaoragada P, Iskandrian AE, Hage FG. J Nucl Cardiol; 2016 Feb; 23(1):101-12. PubMed ID: 26017713 [Abstract] [Full Text] [Related]
5. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. Farzaneh-Far A, Shaw LK, Dunning A, Oldan JD, O'Connor CM, Borges-Neto S. J Nucl Cardiol; 2015 Aug; 22(4):600-7. PubMed ID: 25987234 [Abstract] [Full Text] [Related]
12. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. Iqbal FM, Hage FG, Ahmed A, Dean PJ, Raslan S, Heo J, Iskandrian AE. JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068 [Abstract] [Full Text] [Related]
13. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging. Amer KA, Hurren JR, Edwin SB, Cohen G. Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259 [Abstract] [Full Text] [Related]
14. Long-term prognostic value of myocardial perfusion imaging in octogenarians able to undergo treadmill exercise stress testing. Katsikis A, Theodorakos A, Papaioannou S, Tsapaki V, Kolovou G, Drosatos A, Koutelou M. J Nucl Cardiol; 2014 Dec; 21(6):1213-22. PubMed ID: 25189145 [Abstract] [Full Text] [Related]
15. Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging. Lin LF, Cheng CY, Hou CH, Ku CH, Tseng NC, Shen DH. J Nucl Cardiol; 2014 Jun; 21(3):563-9. PubMed ID: 24627347 [Abstract] [Full Text] [Related]